Abstract
The adenosine (A1) receptor agonist, GR79236 (N-[(1S,trans)-2-hydroxycyclopentyl]adenosine), inhibits catecholamine-induced lipolysis in vitro, but the short-term metabolic and haemodynamic effects have not been previously reported in the fructose fed model of insulin resistance, dyslipidaemia and hypertension. This study reports the effects of GR79236 (1 mg/kg/day for 8 days) on nonesterified free fatty acid and triglyceride metabolism, oral and i.v. glucose tolerance, blood pressure and heart rate, and insulin sensitivity, in normal rats and rats fed a fructose-enriched diet. In normal rats, GR79236 significantly reduced fasting glucose (25%), free fatty acid (50%) and triglyceride (55%) concentrations, and improved glucose tolerance (AUC[glu] 21.2 +/- 1.3 vs. 16.5 +/- 1.1 mmol h/l, p < 0.05). Fructose feeding induced a state of insulin resistance and dyslipidaemia, as shown by an increase in steady-state plasma glucose levels (7.1 vs. 6.1 mmol/l), impaired i.v. glucose tolerance and a 3-fold rise in fasting triglyceride levels; fructose-fed rats also developed a significant increase in blood pressure. GR79236 ameliorated the effects of fructose feeding on fatty acid and triglyceride levels, and blood pressure, and improved i...Continue Reading
References
Nov 15, 1976·The Biochemical Journal·D StansbieR M Denton
Jul 1, 1979·Diabetes·L AxelrodD B Martin
Oct 1, 1979·Diabetes·L AxelrodD B Martin
Jun 5, 1992·European Journal of Pharmacology·R A ChallissL Budohoski
May 1, 1992·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·M MassiG Costa
Mar 1, 1992·Diabetes Care·R A DeFronzoE Ferrannini
Jan 1, 1991·Diabetes·A Green, J L Johnson
Jul 1, 1990·Physiological Reviews·R A Olsson, J D Pearson
Apr 1, 1988·Metabolism: Clinical and Experimental·C E Mondon, G M Reaven
Nov 1, 1987·Hypertension·I S HwangG M Reaven
Aug 1, 1988·Hypertension·G M ReavenB B Hoffman
Apr 1, 1985·The Journal of Clinical Investigation·S LilliojaB V Howard
Jan 15, 1985·Biochemical Pharmacology·D D MylesI F Skidmore
Feb 1, 1973·Journal of Applied Physiology·R D Buñag
May 1, 1967·The Journal of Physiology·S Otway, D S Robinson
May 1, 1967·The Journal of Physiology·S Otway, D S Robinson
Jun 1, 1982·Metabolism: Clinical and Experimental·T A TobeyG M Reaven
Mar 23, 1995·Molecular and Cellular Biochemistry·L HeseltineR Taylor
May 1, 1995·Blood Pressure·R DonnellyG M Reaven
May 1, 1994·Clinical Science·C S ThompsonD P Mikhailidis
May 12, 1994·European Journal of Pharmacology·C J GardnerP Strong
Feb 1, 1994·Diabetologia·P Ebeling, V A Koivisto
Jun 1, 1994·The Journal of Clinical Investigation·G BodenL Rossetti
Jan 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·K F LaNoue, L F Martin
Jun 1, 1993·Clinical Science·P StrongD P Martin
Feb 1, 1996·Hypertension·J A SimonJ T Bernert
Oct 1, 1995·Pharmacology·L A MerkelB F Cox
Oct 1, 1995·Diabetologia·G PaolissoE Ravussin
Sep 15, 1996·Circulation·B D BertoletC J Pepine
Nov 1, 1996·Metabolism: Clinical and Experimental·K U LeeS W Park
Apr 13, 1963·Lancet·P J RANDLEE A NEWSHOLME
Citations
Jul 27, 2001·Mechanisms of Ageing and Development·A R HipkissM J Carrier
Jun 29, 2012·Journal of Medicinal Chemistry·Ilia KorboukhJian Jin
Nov 18, 2008·Expert Opinion on Investigational Drugs·Elfatih Elzein, Jeff Zablocki
Jun 25, 2021·Reviews in Endocrine & Metabolic Disorders·Olakunle Sanni, G Terre'Blanche